House Health Reform Bill Nets $48 Bil. From Pharma - CBO
The Congressional Budget Office has put a value on the net savings that would accrue to the federal government through drug rebate and discount provisions in the pending House health care reform bill: $48 billion over 10 years
You may also be interested in...
As health care reform approaches a House-Senate conference, there is speculation that pharma will commit more money in order to keep the door closed on broader rebates.
Speaker Pelosi holds press conference with AARP to announce revisions to the coverage gap provisions in the bill.
Democratic Sen. Bill Nelson of Florida may have made a tactical error in bringing up an amendment to mandate drug rebates under Medicare Part D during the Senate Finance Committee's markup of health reform legislation